BILICANTASE, created in 1970 (France), from 1185 sister brands and 4958 competing brands. BILICANTASE is owned by MERCK KGAA, listed on the stock exchange of Francfort The ISIN, the company's International Securities Identification Number, is DE0006599905. BILICANTASE is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
MERCK KGAA
(BILICANTASE)
over 5 years*
EUR 224.92